Stay updated on Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T15:25:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added an explicit mention of 'Oropharynx cancer' as a study topic and added a Resources entry for the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-02-25T06:40:02.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding lapse notice (and Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:00:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and a site revision tag (v3.4.1) were added, replacing the previous revision (v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-03T23:46:08.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated footer/version text (Last Update Submitted that Met QC Criteria, Revision: v3.4.0). Removed the previous wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-27T21:08:46.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer/policy updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-22T22:56:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.